Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov;66(2):310-318.
doi: 10.1007/s12020-019-02029-1. Epub 2019 Jul 31.

Mammosomatotroph and mixed somatotroph-lactotroph adenoma in acromegaly: a retrospective study with long-term follow-up

Liang Lv  1 , Yong Jiang  1 , Senlin Yin  1 , Yu Hu  1 , Cheng Chen  1 , Weichao Ma  1 , Shu Jiang  1 , Peizhi Zhou  2
Affiliations

Mammosomatotroph and mixed somatotroph-lactotroph adenoma in acromegaly: a retrospective study with long-term follow-up

Liang Lv et al. Endocrine. 2019 Nov.

Abstract

Purpose: Although well-documented from pathological aspect, the clinical features and outcomes of acromegaly with mammosomatotroph (MSA) and mixed somatotroph-lactotroph adenoma (MSLA) are seldom reported. Thus, in this study, we analyzed and reported the clinical data about MSAs and MSLAs.

Methods: We retrospectively reviewed medical records of patients with acromegaly in our institution during 2008-2017. Growth hormone (GH)-secreting adenomas were categorized into pure somatotroph adenoma (PSA), MSA and MSLA based on inclusion and exclusion criteria. Clinical information and treatment outcomes during follow-up were analyzed by univariate and multivariate methods.

Results: Among 94 patients within this cohort, PSAs, MSAs, and MSLAs accounted for 53, 28 and 13 cases, respectively. MSAs often had smaller size, lower frequency of cavernous sinus invasion and higher gross total resection (GTR) rate. MSLAs were characterized by bigger tumor size, higher frequency of preoperative hyperprolactinemia, and lower GTR rate. Thus, MSLAs had worse long-term biological remission rate than MSAs and PSAs (15.4% vs. 50.0% and 26.4%, p = 0.0371). Gender (male, OR = 0.784, p = 0.011) and tumor volume (OR = 0.784, p = 0.020) were independent predictors for long-term biological remission in binary logistic regression. Subgroup analyses indicated that postoperative nadir GH level (GH-7, HR = 1.242, p = 0.001) was the only risk factor for tumor recurrence for patients with GTR.

Conclusions: Our results provide valuable insights into clinicopathological features of acromegaly. MSAs were relatively smaller lesions with better prognosis. MSLAs were more aggressive with massive size, invasiveness and preoperative hyperprolactinemia. Tumor size and GH-7 were significantly associated with biological remission and tumor relapse after GTR, respectively.

Keywords: Acromegaly; Mammosomatotroph adenoma; Mixed somatotroph-lactotroph adenoma; Remission.

PubMed Disclaimer

References

    1. J Clin Endocrinol Metab. 2014 Feb;99(2):478-85 - PubMed
    1. Cancer. 1981 Feb 15;47(4):761-71 - PubMed
    1. Endocrine. 2015 May;49(1):231-41 - PubMed
    1. J Clin Endocrinol Metab. 2014 Nov;99(11):3933-51 - PubMed
    1. Eur J Endocrinol. 2010 Jun;162(6):1027-33 - PubMed

Publication types

LinkOut - more resources